Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b

• Main Authors: Albert Qin (Author), Daoxiang Wu (Author), Jason Liao (Author), Shuping Xie (Author), Haoqi Chen (Author), Yucheng Gao (Author), Jie Cui (Author), Xia Su (Author), Narihisa Miyachi (Author), Toshiaki Sato (Author), Yaning Li (Author), Jingjing Zhang (Author), Weihong Shen (Author), Wei Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ropeginterferon alfa-2b (Ropeg) is approved for the treatment of adults with polycythemia vera (PV). This report aims to analyze the ethnic sensitivity of Ropeg for the treatment of PV, comparing the pharmacokinetics (PK), efficacy, and safety profiles across diverse ethnic groups. We conducted a re...